...
首页> 外文期刊>Annals of Clinical and Laboratory Science: Official Journal of the Association of Clinical Scientists >Molecular predictive factors for local recurrence and distant metastasis of breast cancer after lumpectomy with postoperative radiation therapy.
【24h】

Molecular predictive factors for local recurrence and distant metastasis of breast cancer after lumpectomy with postoperative radiation therapy.

机译:术后放疗治疗乳房肿块切除术后乳腺癌局部复发和远处转移的分子预测因素。

获取原文
获取原文并翻译 | 示例
           

摘要

To determine the risk factors associated with the recurrence and metastasis of breast cancer after lumpectomy with postoperative radiation therapy, 112 cases were studied who had been treated during a period of 11 years at the University of Florida Health Science Center/Jacksonville. The patients were evaluated for their age, race, and clinical stage, as well as the tumor grade, stage, histological type, and node involvement. Among these cases, four (4%) recurred locally within a year of treatment; 10 (9%) cases presented with distant metastasis within three years. No obvious clinical risk factors were identified for local recurrence; however, positive-node status seemed to be associated with distant metastasis. The primary tumors of these cases were then studied using immunohistochemical staining to evaluate the potential prognostic value of tumor markers such as estrogen receptor (ER), progesterone receptor (PR), tumor suppressor gene p53, HER-2eu oncogene, and multi-drug resistance gene (MDR). The expression of p53 was associated with all local recurrence cases as well as 50% of those who had metastasis. The expression of MDR was observed in 80% of the distant metastatic cases. This preliminary result may warrant further studies on larger number of cases to assess the predictive value of p53 and MDR in the outcome of breast cancers in patients treated with postoperative radiation therapy.
机译:为了确定与乳房肿块切除术后放射治疗后乳腺癌复发和转移相关的危险因素,研究了112例在佛罗里达大学健康科学中心/杰克逊维尔市接受了11年治疗的病例。对患者进行了年龄,种族和临床分期以及肿瘤分级,分期,组织学类型和淋巴结转移的评估。在这些病例中,有4名(4%)在一年内在当地复发;三年内有10例(9%)出现远处转移。没有发现局部复发的明显临床危险因素。然而,阳性结节状态似乎与远处转移有关。然后,使用免疫组织化学染色对这些病例的原发肿瘤进行研究,以评估诸如雌激素受体(ER),孕激素受体(PR),抑癌基因p53,HER-2 / neu癌基因和多种肝癌等肿瘤标志物的潜在预后价值。耐药基因(MDR)。 p53的表达与所有局部复发病例以及50%转移的病例相关。在80%的远处转移病例中观察到MDR的表达。该初步结果可能需要对更多病例进行进一步研究,以评估p53和MDR对术后放射治疗患者乳腺癌预后的预测价值。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号